Scoop: Eli Lil­ly agrees to ac­quire an­oth­er Eu­ro­pean ADC biotech

Last year
Startups
Deals

FDA ap­proves Mer­ck­'s Keytru­da for be­fore and af­ter lung can­cer surgery

Last year
R&D
FDA+

Rhythm’s drug shows 25% drop in BMI over one year for pa­tients with rare form of obe­si­ty

Last year
R&D

Up­dat­ed: ES­MO em­bar­go break leads can­cer con­fer­ence to re­lease da­ta for Bris­tol My­ers, J&J, No­var­tis, As­traZeneca

Last year
R&D
Pharma

US vs. Eu­rope: New re­search pa­per com­pares drug re­view times across bor­ders

Last year
Pharma
FDA+

'Con­sti­tu­tion­al ar­gu­ments fail': Gov­ern­ment lawyers slam suits from Bris­tol My­ers, Janssen over drug price ...

Last year
Law

J&J lays out plans for po­ten­tial Supreme Court pe­ti­tion in talc lit­i­ga­tion

Last year
Pharma
Law

Q&A: Lil­ly sci­ence chief Dan Skovron­sky talks deal­mak­ing, AI and con­sis­tent in­vest­ing

Last year
Deals
Pharma

Ama­zon’s head of health ser­vices shares why con­sumers could be a dis­rup­tive force to the health­care in­dus­try

Last year
Health Tech

Jin­gle all the way? Phar­ma mar­keters adapt their mu­sic strate­gies for chan­nels like Tik­Tok

Last year
Marketing

Apel­lis’ C3 in­hibitor shows bio­mark­er im­pact in small PhII rare kid­ney dis­ease tri­al

Last year
R&D

Mar­ket­ingRx roundup: Amer­i­cans still di­vid­ed over Covid boost­ers; Am­gen ramps up ac­tiv­i­ty on Threads

Last year
Marketing

Evelo dealt an­oth­er blow with a PhII fail, plans for strate­gic al­ter­na­tives

Last year
R&D

Ul­tragenyx to spin off com­pa­ny to de­vel­op ‘high risk, high re­turn’ gene ther­a­py for Alzheimer’s dis­ease

Last year
Startups
R&D

Nkar­ta trims head­count as it sets sights on au­toim­mune cell ther­a­py

Last year
People
Cell/Gene Tx

Ther­mo Fish­er reels in pro­teomics com­pa­ny Olink in $3.1B deal

Last year
Deals
Outsourcing

Roche en­lists Monte Rosa for can­cer, neu­ro dis­cov­ery deal with $50M up­front

Last year
Deals

Lu­men gets $16M for C. diff drug; Flash­point’s seed round; Am­pli­fi­er ex­pands Se­ries A

Last year
News Briefing

Gen­er­al Cat­a­lyst’s Daryl Tol lays out why he thinks he can help health sys­tems trans­form them­selves

Last year
Health Tech

Obe­si­ty treat­ment start­up Ilant Health launch­es with $3M

Last year
Startups
Health Tech

Af­ter con­sumer spin­off, John­son & John­son re­ports Q3 sales in­crease and bumps up full-year guid­ance

Last year
Pharma

Mayo Clin­ic-backed Nu­cle­us Ra­dio­Phar­ma rais­es $56M in Se­ries A to boost CD­MO ser­vices

Last year
Financing
Manufacturing

PureTech gives up on re­gain­ing con­trol of Gele­sis and its weight loss pill

Last year
Deals

Lon­za braces for 2024 prof­it im­pact due to Mod­er­na, Ko­di­ak man­u­fac­tur­ing cuts

Last year
Manufacturing
First page Previous page 262263264265266267268 Next page Last page
A service from the Financial Times